Sierra Pharmaceuticals Limited. - Company Profile

It is a pharma public limited company based in New Delhi, Delhi, India, established in 1999.
1999 New Delhi, Delhi, India Active
Last Updated:
Access Report
About Sierra Pharmaceuticals Limited.

Sierra Pharmaceuticals Limited., a active public limited company, was established on 14 June 1999 in New Delhi, Delhi, India. Engaging in pharmaceutical retailers & distributors within the pharma sector, it holds CIN: U51397DL1999PLC100240. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.51 M.

It upholds a compliant status. Its leadership includes Veena Sharma (Director), Anil Sharma (Director), Tanuj Sharma (Director). Past directors included Ajay Gupta, Sadhana Gupta. It holds ₹9.92 M open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 71 Church Lanesummon Bazar Bhogal, New Delhi, Delhi.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U51397DL1999PLC100240

  • Registration Number

    100240

  • Incorporation Date

    14 June 1999

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹0.51 M

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.51 M
  • Company Age 26 Year, 7 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 9.92 M
  • Revenue Growth **** 23.95%
  • Profit Growth **** 143.11%
  • Ebitda **** -3.53%
  • Net Worth 4.67%
  • Total Assets -0.84%
Company report

Sierra Pharmaceuticals Limited.

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Sierra Pharmaceuticals Limited. — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Sierra Pharmaceuticals Limited.?
Current Directors
Name Designation Appointment Date Status
Veena Sharma Director 01 Aug 2008 Current
Anil Sharma Director 14 Jun 1999 Current
Tanuj Sharma Director 01 Aug 2008 Current
Archna Sharma Director 14 Jun 1999 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 25 Sep 2009 Past
Pramod Abcsdd Director 25 Sep 2009 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Sierra Pharmaceuticals.

Sierra Pharmaceuticals Limited., for the financial year ended 2022, experienced significant growth in revenue, with a 23.95% increase. The company also saw a substantial improvement in profitability, with a 143.11% increase in profit. The company's net worth moved up by a moderate rise of 4.67%.

Sierra Pharmaceuticals revenue growth over time
Sierra Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 23.95%
*******
*******
*******
*******
Revenue from Operations
*******
 23.82%
*******
*******
*******
*******
Total Assets
*******
 -0.84%
*******
*******
*******
*******
Profit or Loss
*******
 143.11%
*******
*******
*******
*******
Net Worth
*******
 4.67%
*******
*******
*******
*******
EBITDA
*******
 -3.53%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Sierra Pharmaceuticals?

In 2019, Sierra Pharmaceuticals had a promoter holding of 98.43% and a public holding of 1.57%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹9,920,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Others : 0.59 Cr
  • Central Bank Of India : 0.35 Cr
  • State Bank Of India : 0.05 Cr
Latest Charge Details
Date Lender Amount Status
29 Mar 2025 Others ₹0.92 M Open
09 Apr 2024 Others ₹5.00 M Open
08 Oct 2010 Central Bank Of India ₹3.50 M Open
13 Jul 2002 State Bank Of India ₹0.50 M Open

Explore comprehensive loan charge details -

How Many Employees Work at Sierra Pharmaceuticals?

Unlock and access historical data on people associated with Sierra Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Sierra Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sierra Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Sierra Pharmaceuticals
Recent Activity within the Organization
  • Charges

    Progress on A charge with Others amounted to Rs. 0.92 M with Charge ID 101082707 was registered on 29 Mar 2025. was documented.

  • Annual General Meeting

    The activity Sierra Pharmaceuticals Limited. last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.

  • Charges

    The activity A charge with Others amounted to Rs. 5.00 M with Charge ID 100918242 was registered on 09 Apr 2024. was completed.

  • Balance Sheet

    Progress on Sierra Pharmaceuticals Limited. has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was documented.

  • Charges

    Progress on A charge with Central Bank Of India of Rs. 3.50 M registered on 08 Oct 2010 with Charge ID 10247508 was modified on 09 Mar 2013. was documented.

  • Charges

    A charge with Central Bank Of India amounted to Rs. 3.50 M with Charge ID 10247508 was registered on 08 Oct 2010. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Sierra Pharmaceuticals Limited.?

The CIN of Sierra Pharmaceuticals Limited. is U51397DL1999PLC100240.

Where is Sierra Pharmaceuticals Limited. headquartered?

Sierra Pharmaceuticals Limited. is headquartered at 71 Church Lanesummon Bazar Bhogal, New Delhi, Delhi.

When was Sierra Pharmaceuticals Limited. incorporated?

Sierra Pharmaceuticals Limited. was incorporated on 14 June 1999.

Who are the current directors of Sierra Pharmaceuticals Limited.?

The current directors of Sierra Pharmaceuticals Limited. are

What is the primary industry of Sierra Pharmaceuticals Limited.?

The primary industry of Sierra Pharmaceuticals Limited. is Pharma.

Is Sierra Pharmaceuticals Limited. a listed company?

Sierra Pharmaceuticals Limited. is unlisted.

What is the capital structure of Sierra Pharmaceuticals Limited.?

The authorized capital of Sierra Pharmaceuticals Limited. is ₹1.00 M, and the paid-up capital is ₹0.51 M.

What is the compliance status of Sierra Pharmaceuticals Limited.?

The compliance status of Sierra Pharmaceuticals Limited. is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available